Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Oncogenic and immunological functions of USP35 in pan-cancer and its potential as a biomarker in kidney clear cell carcinoma

Fig. 4

Functional role of USP35 in KIRC and its involvement in oncogenic processes. A Correlation analysis of USP35 expression with various oncogenic processes. B GSVA comparing high and low USP35 expression groups in KIRC, highlighting metabolic pathway enrichment. C Circular plot illustrating the association between USP35 expression and several oncogenic pathways. D SNV Neoantigen burden correlation across cancer types in relation to USP35 expression. E GSEA on KEGG gene sets in pan-cancer, highlighting metabolic and immune-related differences between high and low USP35 expression groups. F Functional categorization of pathways associated with USP35 expression

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us